Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

AstraZeneca reported $2.06B in Cost of Sales for its fiscal quarter ending in September of 2023.

Cost Of Sales Change Date
AbbVie USD 6.47B 2.26B Sep/2023
Alcon AG USD 1.04B 18M Sep/2023
Almirall EUR 106.37M 15.74M Jun/2023
Amgen USD 1.81B 36M Sep/2023
Artemis Alpha GBP 490K 17K Jun/2022
AstraZeneca USD 2.06B 91M Sep/2023
Bayer EUR 4.81B 94M Sep/2023
Biogen USD 659.6M 66.9M Sep/2023
Bristol-Myers Squibb USD 2.49B 350M Sep/2023
Eli Lilly USD 1.86B 52.7M Sep/2023
Fresenius Medical Care EUR 3.71B 79M Sep/2023
Galapagos EUR 5.7M 1.43M Sep/2023
Gilead Sciences USD 1.57B 123M Sep/2023
GlaxoSmithKline GBP 2.24B 343M Sep/2023
GRIFOLS EUR 965.65M 79.34M Sep/2023
Haleon 1.08B 43M Sep/2023
Hikma Pharmaceutical USD 694M 32M Jun/2023
Lonza CHF 1.97B 29M Jun/2023
Merck EUR 2.16B 23M Sep/2023
Merck USD 3.68B 313M Sep/2023
Orion EUR 129.8M 6.2M Sep/2023
Pfizer USD 9.63B 6.23B Sep/2023
Philips EUR 2.54B 30M Sep/2023
Recordati EUR 178.54M 30.24M Sep/2023
Regeneron Pharmaceuticals USD 436.4M 31.5M Sep/2023
Roche Holding CHF 7.62B 1.33B Jun/2023
UCB EUR 802M 27M Jun/2023